Who has invested in PTC Therapeutics?

HealthCap Partners, Credit Suisse First Boston, HBM Healthcare Investments are named among the investors backing PTC Therapeutics.

PTC Therapeutics Funding: $250M Raised, IPO

PTC Therapeutics funding overview

PTC Therapeutics is based in South Plainfield, New Jersey. PTC Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include HealthCap Partners, Credit Suisse First Boston, HBM Healthcare Investments. 3 distinct backers are named across the disclosed rounds.

PTC Therapeutics at a glance

Total raised: $250M
Latest round: IPO
Headquarters: South Plainfield, New Jersey
Notable investors: HealthCap Partners, Credit Suisse First Boston, HBM Healthcare Investments

Frequently asked about PTC Therapeutics funding

How much has PTC Therapeutics raised?: PTC Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in PTC Therapeutics?: HealthCap Partners, Credit Suisse First Boston, HBM Healthcare Investments are named among the investors backing PTC Therapeutics.
What was the latest PTC Therapeutics funding round?: The most recent disclosed round is an IPO.
Where is PTC Therapeutics based?: PTC Therapeutics is based in South Plainfield, New Jersey.

We update the PTC Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South Plainfield and their backers are listed below.

PTC Therapeutics Funding: $250M Raised, IPO

PTC Therapeutics funding overview

PTC Therapeutics at a glance

Frequently asked about PTC Therapeutics funding

Companies related to PTC Therapeutics (30)

Browse related funding lists (3)